<DOC>
	<DOCNO>NCT00420628</DOCNO>
	<brief_summary>A multicenter study evaluate safety efficacy Zylet compare vehicle child age 0-6 management lid inflammation ( chalazion/hordeolum )</brief_summary>
	<brief_title>Pediatric Zylet Safety Efficacy Study</brief_title>
	<detailed_description />
	<mesh_term>Chalazion</mesh_term>
	<mesh_term>Hordeolum</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>Child , 0 6 year age , sex race Subject must clinical diagnosis lid inflammation ( e.g . Chalazion/Hordeolum ) least one eye . If eye diagnose lid inflammation , eye treat In good health ( current past relevant medical history ) , base judgment investigator Parent/guardian able willing follow instruction provide informed consent Known hypersensitivity corticosteroid , loteprednol etabonate , component study medication Known hypersensitivity aminoglycosides , tobramycin , component study medication Use concurrent ocular therapy nonsteroidal antiinflammatory agent ( NSAID ) , mast cell stabilizer , antihistamine , decongestant within 48 hour study Use oral topical ophthalmic corticosteroid ( study medication ) within 48 hour study Use systemic antibiotic within 72 hour 14 day study medication treatment duration Use topical ophthalmic antibiotic ( study medication ) within 72 hour study History ocular surgery , include laser procedure , within past six month Anticipation surgical intervention lid inflammation require prior completion study Subjects suspect vernal conjunctivitis , glaucoma kind , viral bacterial conjunctivitis , preseptal cellulitis require systemic antibiotic , dacryocystitis , uveitis , disease condition could interfere safety efficacy evaluation study medication History severe/serious ocular pathology medical condition could result subject 's inability complete study Participation ophthalmic drug device research study within 30 day prior entry study Unlikely comply protocol instruction reason</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>